Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Indegene's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 4,620.3 | 3,325.9 | 2,545.6 |
| Accumulated Depreciation Total | -247.8 | -212 | -182.2 |
| Other Liabilities Total | 290.4 | 73.4 | 107 |
| Accrued Expenses | 143.1 | 101.1 | 113.6 |
| Common Stock Total | 48.1 | 47.9 | 44.4 |
| Other Equity Total | 197.7 | 62 | 33.9 |
| Other Current Assets Total | 8 | 0.1 | 36.5 |
| Prepaid Expenses | 90.1 | 47.3 | 73.5 |
| Total Assets | 4,620.3 | 3,325.9 | 2,545.6 |
| Current Portof LT Debt/Capital Leases | 39.4 | 29.2 | 81.3 |
| Additional Paid-In Capital | 1,013.6 | 992.9 | 246.9 |
| Cash | 300.8 | 241 | 188.6 |
| Total Equity | 3,138.7 | 2,615.6 | 1,429.1 |
| Long Term Investments | 57.1 | Not available | Not available |
| Retained Earnings(Accumulated Deficit) | 1,879.3 | 1,512.8 | 1,103.9 |
| Total Common Shares Outstanding | 24.05 | 23.96 | 22.21 |
| Property/Plant/Equipment Total-Gross | 453.6 | 350.5 | 296.6 |
| Tangible Book Valueper Share Common Eq | 63.24 | 86.5 | 40.43 |
| Goodwill Net | 1,134.3 | 356.5 | 333 |
| Total Liabilities | 1,481.6 | 710.3 | 1,116.5 |
| Total Debt | 144.4 | 101.6 | 489.6 |
| Short Term Investments | 1,180.6 | 1,423.3 | 798.9 |
| Cashand Short Term Investments | 1,481.4 | 1,664.3 | 987.5 |
| Total Receivables Net | 1,020 | 805.2 | 680 |
| Notes Payable/Short Term Debt | 0 | 0 | 9.7 |
| Accounts Receivable-Trade Net | 984.2 | 758.3 | 654 |
| Property/Plant/Equipment Total-Net | 205.8 | 138.5 | 114.4 |
| Total Current Liabilities | 1,086.2 | 564.5 | 610.9 |
| Total Inventory | 18.9 | 13.1 | 13.3 |
| Accounts Payable | 187.1 | 101.2 | 118.1 |
| Other Currentliabilities Total | 716.6 | 333 | 288.2 |
| Total Long Term Debt | 105 | 72.4 | 398.6 |
| Intangibles Net | 483.3 | 186.2 | 198.4 |
| Other Long Term Assets Total | 104.2 | 105.6 | 84.7 |
| Note Receivable-Long Term | 17.2 | 9.1 | 24.3 |
| Total Current Assets | 2,618.4 | 2,530 | 1,790.8 |
| Capital Lease Obligations | 105 | 72.4 | 65.2 |
| Long Term Debt | Not available | 0 | 333.4 |
PEG Ratio2.23
Price to Sale Ratio3.76
Debt 5Yr CAGR %22.95
Operating Margin 12m12.29
Operating Margin 5y Avg14.98
Net Profit Margin 12m10.51
Net Profit Margin 5y12.19
Dividend Yield %0.42
Overall RiskBalanced risk
Board Risk31.56
ConsensusHold
Consensus score2.83
Analyst opinions6
Strong Sell count1
Sell count0
Hold count3
Buy count1
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Delhivery | INR 469.9 | 35,198.08 | 226.01 | — |
| Urban Company | INR 142.5 | 22,053.45 | Not available | — |
| BLS International Services | INR 253.8 | 10,449.98 | 14.15 | — |
| Axiscades Technologies | INR 1,631.95 | 6,917.58 | 83.28 | — |
| TVS Supply Chain Solutions | INR 132 | 5,823.58 | 26.67 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Nomura Adjusts Indegene's Price Target to INR500 From INR480, Keeps at Neutral marketscreener.com
Price to sales forward of Indegene Limited – NSE:INDGN TradingView
Indegene Limited Actuals & Estimates (NSE:INDGN) TradingView
INDGN Forecast — Price Target — Prediction for 2027 TradingView
Indegene Ltd. Share Price Today - Indegene Ltd. Stock Price Live NSE/BSE CNBC TV18
Indegene confirms no identifiable promoter in FY26 scanx.trade
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.
Indegene has the symbol INDGN and ISIN - INE065X01017.
Indegene is currently trading at INR 570.00.
Indegene has a year high of INR 596.80 and a year low of INR 414.00.
Indegene has a market capitalization of INR 13,182.68 crore.
Indegene has a P/E ratio of 31.44.
Indegene has a dividend yield of 0.42%.
Indegene has revenue of INR 3,510.50 crore, net income of INR 401.10 crore, and EPS of INR 17.26.
Indegene has a book value of NA.
Indegene has a debt-to-equity ratio of NA.
Indegene has a price-to-book ratio of NA and a price-to-sales ratio of 3.76.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.